Filing Details
Cellectar Biosciences, Inc. (NASDAQ:CLRB) filed a Form 8-K with the Securities and Exchange Commission on July 10, 2026, disclosing a material event.
8k filedNASDAQ:CLRB
Cellectar Biosciences, Inc. (CLRB) Reports Material Event to SEC
Filing Details Cellectar Biosciences, Inc. (NASDAQ:CLRB) filed a Form 8-K with the Securities and Exchange Commission on July 10, 2026, disclosing a material event. Market Context…
Market Context
Cellectar Biosciences, Inc.'s stock currently trades at $2.82 with a market capitalization of $12.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Cellectar Biosciences, Inc.'s stock.
All SEC filings for Cellectar Biosciences, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CLRB Stock Page
Frequently Asked Questions
Where can I read CLRB's SEC filings?
Browse all filings on our CLRB SEC filings page.
What types of SEC filings does Cellectar Biosciences, Inc. file?
Public companies like Cellectar Biosciences, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.